| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |